CVS Health says it is moving away from the complex formulas that determine the prices of the prescription drugs it sells, a move that could upend how pharmacies are paid wsj.com/health/healthc… via The Wall Street Journal

Toxicologists, by nature, would seem to have to be fairly calm people. But the story of calcium disosodium EDTA, one of the few antidotes for severe lead poisoning, can get them pretty fired up. Here’s why: cnn.com/2023/12/06/hea…

U.S. regulators are poised to approve the first gene-editing treatment in a breakthrough for patients with sickle cell disease, a long overlooked blood disorder. Another gene therapy for SCD could be approved later this month. cnbc.com/2023/12/07/cri…

The FDA is expected to approve a landmark gene-editing treatment for sickle cell disease. Angelica Peebles reports.

We spoke to Vertex CEO Reshma Kewalramani following today's approval of Casgevy for sickle cell disease. Here's what she had to say about price, access and whether the treatment can be considered a cure. cnbc.com/video/2023/12/…

Could sickle cell someday be treated not with CRISPR, but with a pill? Novartis $NVS teases some very intriguing early data statnews.com/2023/12/13/sic…

Remember when Target $TGT said it was closing nine stores because theft and organized retail crime were making them too dangerous to run? Turns out crime incidents are higher at the locations it kept open nearby cnbc.com/2023/12/19/tar…

🏥💵🔍 SCOOP: One-fifth of US hospitals have been warned that they've violated rules requiring them to disclose prices. The government hasn't made their names public, but records we got show they're from some of the biggest US hospital systems. bloomberg.com/news/articles/…

Back in October, I spent time talking to $BMY's Ken Rhodes about the pharma's new emphasis on neuroscience as a research focus. He spoke of a mission to "put the CNS back in BMS," which sounds more convincing now: biopharmadive.com/news/bristol-m…

No JPM for me this year. Have my hands full back east. See you in a few months!

First day of work after nearly four wonderful months with my little one. Looking forward to getting back to it!

Just in: Walmart is closing all of its health centers and its telehealth service. It’s a striking end to the retailer’s effort to disrupt the health-care industry with lower prices for the doctor and dentist. cnb.cx/4dg8jS5 reported w/Annika Kim Constantino $WMT

These two brothers meet the stereotypical profile of people w/ cystic fibrosis in every way but one: They aren’t white — a fact that delayed their care and undermined their health. nytimes.com/2024/05/29/wel…

Pfizer drug extends life for patients with rare lung cancer usually seen in nonsmokers nbcnews.com/health/cancer/…

Walmart’s hometown of Bentonville has changed a lot since founder Sam Walton put it on the map. With craft cocktails, mountain bikes and art, the Arkansas town is booming and becoming more expensive. $WMT cnb.cx/3X5ed2W

CVS store-brand drugs are a few dollars cheaper and consumers could assume they're the same as the big, name brand ones. Mold, bacteria and barefoot factory workers say otherwise. Read my latest investigation: bloom.bg/45hcae9

An inside look at Pfizer's pandemic-fueled rise and fall from Annika Kim Constantino cnbc.com/2024/06/28/pfi…

On the Big Take podcast, Madison Muller takes David Gura to Ozempictown, USA. (And no, it’s not where you think it is.) trib.al/SkySyO7

Huge morning for Lilly. And Dave Ricks telling us we're only in the bottom of the first inning. Full $LLY interview here: cnbc.com/video/2024/08/…

Spent a few days in Indiana this week at Lilly's HQ, labs and the future home of a massive manufacturing complex to learn what's ahead for Lilly in obesity and beyond cnbc.com/2024/10/02/eli…